Erratum: Prenatal diagnosis of a de novo partial trisomy 10p12.1-12.2 pter originating from an unbalanced translocation onto 15qter and confirmed with array CGH (Prenatal Diagnosis (2009) 28, (770-772) DOI: 10.1002/pd.2409);Assessing the role of placental trisomy in preeclampsia and intrauterine growth restriction

Prenatal Diagnosis

Volumn 30, Issue 1, 2010, Pages 1-8

  Robinson, Wendy P ^a   Peñaherrera, Maria S ^a   Jiang, Ruby ^a   Avila, Luana ^a   Sloan, Jennifer ^a   McFadden, Deborah E ^a   Langlois, Sylvie ^a   Von Dadelszen, Peter ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Intrauterine growth restriction; Mosaicism; Placenta; Preeclampsia; Trisomy

Indexed keywords

CHORIONIC GONADOTROPIN;

ARTICLE; BIOPSY; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; EMBRYO; EVALUATION; FEMALE; HUMAN; HUMAN TISSUE; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; MATERNAL SERUM; PREECLAMPSIA; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; SEX CHROMOSOME MOSAICISM; TRISOMY;

EID: 75149125794     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.2558     Document Type: Erratum

References (58)

1. Amiel A, Bouaron N, Kidron D, et al. 2002. CGH in detection of confined placental mosaicism (CPM) in placentas of abnormal pregnancies. Prenat Diagn 22: 752-758.
2. Artan S, Basaran N, Hassa H, et al. 1995. Confined placental mosaicsm in term placenta: analysis of 125 cases. Prenat Diagn 15: 1135-1142.
3. Audibert F, Friedman SA, Frangieh AY, Sibai BM. 1996. Clinical utility of strict diagnostic criteria for the HELLP (hemolysis, elevated liver enzymes, and low platelets) syndrome. Am J Obstet Gynecol 175: 460-464.
4. Barker DJ. 1997. The long-term outcome of retarded fetal growth. Clin Obstet Gynecol 40: 853-863.
5. Barker DJ, Eriksson JG, Forsen T, Osmond C. 2002. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 31: 1235-1239.
6. Barrett IJ, Lomax BL, Loukianova T, et al. 2001. Comparative genomic hybridization: a new tool for reproductive pathology. Arch Pathol Lab Med 125: 81-84.
7. Benn P. 1998. A review of trisomy 16 and trisomy 16 mosaicism. Am J Med Genet 79: 121-133.
8. Bernard LE, Kalousek DK, Barrett IJ, et al. 1995. Confined placental mosaicism for trisomy 2 with fetal maternal uniparental disomy of chromosome 2. Am J Hum Genet 57: A51.
9. Bernasconi F, Karagüzel A, Celep F, et al. 1996. Normal phenotype with maternal isodisomy in a female with two isochromosomes: i(2p) and i(2q). Am J Hum Genet 59: 1114-1118.
10. Brun JL, Gangbo F, Wen ZQ, et al. 2004. Prenatal diagnosis and management of sex chromosome aneuploidy: a report on 98 cases. Prenat Diagn 24: 213-218.
11. Diego-Alvarez D, Rodriguez de Alba M, Cardero-Merlo R, et al. 2007. MLPA as a screening method of aneuploidy and unbalanced chromosomal rearrangements in spontaneous miscarriages. Prenat Diagn 27: 765-771.
12. Douglas KA, Redman CW. 1994. Eclampsia in the United Kingdom. Br Med J 309: 1395-1400.
13. Fryburg J, Dimaio M, Yang-Feng T, Mahoney M. 1993. Follow-up of pregnancies complicated by placental mosaicism diagnosed by chorionic villus sampling. Prenat Diagn 13: 481-494.
14. Gagnon A, Wilson RD, Audibert F, et al. 2008. Obstetrical complications associated with abnormal maternal serum markers analytes. J Obstet Gynaecol Can 30: 918-949.
15. Gibbons B, Cheng HH, Yoong AK, Brown S. 1997. Confined placental mosaicism for trisomy 2 with intrauterine growth retardation and severe oligohydramnios in the absence of uniparental disomy in the fetus [letter]. Prenat Diagn 17: 689-690.
16. Granger JP, Alexander BT, Llinas MT, et al. 2001. Pathophysiology of hypertension during preeclampsia linking placental ischemia with endothelial dysfunction. Hypertension 38: 718-722.
17. Hansen WF, Bernard LE, Langlois S, et al. 1997. Maternal uniparental disomy of chromosome 2 and confined placental mosaicism for trisomy 2 in a fetus with intrauterine growth restriction, hypospadias and oligohydramnios. Prenat Diagn 17: 443-450.
18. Harrison K, Eisenger K, Anyane-Yeboa K, Brown S. 1995. Maternal uniparental disomy of chromosome 2 in a baby with trisomy 2 mosaicism in amniotic fluid culture. Am J Med Genet 58: 147-151.
19. Heide E, Heide KG, Rodewald A. 2000. Maternal uniparental disomy (UPD) for chromosome 2 discovered by exclusion of paternity. Am J Med Genet 92: 260-263.
20. Henderson KG, Shaw TE, Barrett IJ, et al. 1996. Distribution of mosaicism in human placentae. Hum Genet 97: 650-654.
21. Huang A, Adusumalli J, Patel S, et al. 2009. Prevalence of chromosomal mosaicism in pregnancies from couples with infertility. Fertil Steril 91: 2355-2360.
22. Kaiser-Rogers KA, McFadden DE, Livasy CA, et al. 2005. Androgenetic/biparental mosaicism causes placental mesenchymal dysplasia. J Med Genet 43: 187-192.
23. Kalousek DK. 1994. Current topic: confined placental mosaicism and intrauterine fetal development. Placenta 15: 219-230.
24. Kennerknecht I, Kramer S, Grab D, et al. 1993. A prospective cytogenetic study of third-trimester placentae in small-for-date but otherwise normal newborns. Prenat Diagn 13: 257-269.
25. Kotzot D. 1999. Abnormal phenotypes in uniparental disomy (UPD): fundamental aspects and a critical review with bibliography of UPD other than15. Am J Med Genet 82: 265-274.
26. Kramer MS, Platt RW, Wen SW, et al. 2001. A new and improved population-based Canadian reference for birth weight for gestational age. Pediatrics 108: E35.
27. Krishnamoorthy A, Gowen LC, Boll KE, et al. 1995. Chromosome and interphase analysis of placental mosaicism in intrauterine growth retardation. J Perinatol 15: 47-50.
28. Lackland DT, Egan BM, Ferguson PL. 2003. Low birth weight as a risk factor for hypertension. J Clin Hypertens (Greenwich) 5: 133-136.
29. Langlois S, Yong PJ, Yong SL, et al. 2006. Post-natal follow-up of prenatally diagnosed trisomy 16 mosaicism. Prenat Diagn 26: 548-558.
30. Ledbetter DH, Zachary JM, Simpson JL, et al. 1992. Cytogenetic results from the U.S. Collaborative Study on CVS. Prenat Diagn 12: 317-345.
31. Lestou VS, Barrett IJ, Harrington B, Kalousek DK. 1997. CPM and risk of fetal IUGR: definition of the aneuploidy levels in placental trophoblast and chorion by FISH and CGH. Cytogenet Cell Genet 77: 80.
32. Lestou VS, Desilets V, Lomax BL, et al. 2000. Comparative genomic hybridization: a new approach to screening for intrauterine complete or mosaic aneuploidy. Am J Med Genet 92: 281-284.
33. Lomax BL, Lestou VS, Barrett IJ, Kalousek DK. 1998. Confined placental mosaicism for chromosome 7 detected by comparative genomic hybridization. Prenat Diagn 18: 752-754.
34. Lomax B, Tang S, Separovic E, et al. 2000. Comparative genomic hybridization in combination with flow cytometry improves results of cytogenetic analysis of spontaneous abortions. Am J Hum Genet 66: 1516-1521.
35. Magee LA, Helewa M, Moutquin JM, van Dadelszen P. 2008. Diagnosis, evaluation, and management of the hypertensive disorders of pregnancy. J Obstet Gynaecol Can 30: S1-S48.
36. Minor A, Harmer K, Peters N, et al. 2006. Investigation of confined placental mosaicism (CPM) at multiple sites in post-delivery placentas derived through intracytoplasmic sperm injection (ICSI). Am J Med Genet A 140: 24-30.
37. Noomen P, van den Berg C, de Ruyter J, et al. 2001. Prevalence of tetraploid metaphases in semidirect and cultured chorionic villi. Fetal Diagn Ther 16: 129-132.
38. Papadogiannakis N, Iwarsson E, Taimi T, et al. 2008. Lack of aneuploidy for chromosomes 15, 16, and 18 in placentas from small-for- gestational-age liveborn infants. Am J Obstet Gynecol 198: 231 e1-e7.
39. Robinson WP. 2000. Mechanisms leading to uniparental disomy in humans. Bioessays 22: 452-459.
40. Robinson WP, Barrett IJ, Bernard L, et al. 1997. A meiotic origin of trisomy in confined placental mosaicism is correlated with presence of fetal uniparental disomy, high levels of trisomy in trophoblast and increased risk of fetal IUGR. Am J Hum Genet 60: 917-927.
41. Robinson WP, Barrett IJ, Kuchinka B, et al. 2002. Origin of amnion and implications for evaluation of the fetal genotype in cases of mosaicism. Prenat Diagn 22: 1078-1087.
42. Robinson WP, Lauzon JL, Innes AM, et al. 2007. Origin and outcome of pregnancies affected by androgenetic/biparental chimerism. Hum Reprod 22: 1114-1122.
43. Sarto GE, Stubblefield PA, Therman E. 1982. Endomitosis in human trophoblast. Hum Genet 62: 228-232.
44. Schaeffer AJ, Chung J, Heretis K, et al. 2004. Comparative genomic hybridization-array analysis enhances the detection of aneuploidies and submicroscopic imbalances in spontaneous miscarriages. Am J Hum Genet 74: 1168-1174.
45. Shaffer LG, Coppinger J, Alliman S, et al. 2008. Comparison of microarray-based detection rates for cytogenetic abnormalities in prenatal and neonatal specimens. Prenat Diagn 28: 789-795.
46. Smidt-Jensen S, Lind A-M. 1993. Cytogenetic analysis of 2928 cvs sanples and 1075 amniocenteses from randomized studies. Prenat Diagn 13: 723-740.
47. Stipoljev F, Latin V, Kos M, et al. 2001. Correlation of confined placental mosaicism with fetal intrauterine growth retardation. A case control study of placentas at delivery. Fetal Diagn Ther 16: 4-9.
48. von Dadelszen P, Magee LA, Roberts JM. 2003. Subclassification of preeclampsia. Hypertens Pregnancy 22: 143-148.
49. Wapner RJ, Simpson JL, Golbus MS, et al. 1992. Chorionic mosaicism: association with fetal loss but not with adverse perinatal outcome. Prenat Diagn 12: 347-355.
50. Wiles NJ, Peters TJ, Leon DA, Lewis G. 2005. Birth weight and psychological distress at age 45-51 years: results from the Aberdeen Children of the 1950s cohort study. Br J Psychiatry 187: 21-28.
51. Wilkins-Haug L, Roberts DJ, Morton CC. 1995. Confined placental mosaicism and intrauterine growth retardation: a case-control analysis of placentas at delivery. Am J Obstet Gynecol 172: 44-50.
52. Wilkins-Haug L, Quade B, Morton CC. 2006. Confined placental mosaicism as a risk factor among newborns with fetal growth restriction. Prenat Diagn 26: 428-432.
53. Wolstenholme DR. 1996. Confined placental mosaicism for trisomies 2,3,7,8,9,16, and 22: their incidence, likely origins, and mechanisms for cell lineage compartmentalization. Prenat Diagn 16: 511-524.
54. Wolstenholme J, Rooney DE, Davison EV. 1994. Confined placental mosaicism, IUGR, and adverse pregnancy outcome: a controlled retrospective U.K. collaborative survey. Prenat Diagn 14: 345-361.
55. Yong P. 2006. Three chromosomes and a baby: Cytogenetic, biological, and clinical aspects of the trisomic placenta. PhD thesis. Experimental Medicine. University of British Columbia, Vancouver.
56. Yong PJ, Barrett IJ, Kalousek DK, Robinson WP. 2003. Clinical aspects, prenatal diagnosis, and pathogenesis of trisomy 16 mosaicism. J Med Genet 40: 175-182.
57. Yong PJ, Langlois S, von Dadelszen P, Robinson W. 2006. The association between preeclampsia and placental trisomy 16 mosaicism. Prenat Diagn 26: 956-961.
58. Zybina TG, Frank HG, Biesterfeld S, Kaufmann P. 2004. Genome multiplication of extravillous trophoblast cells in human placenta in the course of differentiation and invasion into endometrium and myometrium. II. Mechanisms of polyploidization. Tsitologiia 46: 640-648.